| Colorectal Neoplasm studied in …STUDIED_INderived10 of 8,597show all (up to 200) |
|---|
| → studied in | NCT00034216recruiting Collection of Blood From Patients With Cancer · condition mapped CURATED_EXACT · 8,597 trials mapped (2,274 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595957recruiting Genomic Services Research Program · condition mapped CURATED_EXACT · 8,597 trials mapped (2,274 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03364621active not recruiting Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy · condition mapped CURATED_BROADER · 8,597 trials mapped (2,274 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03623464NA · suspended RCT of Mobile Apps & FitBit v. Usual Care · condition mapped CURATED_EXACT · 8,597 trials mapped (2,274 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793958Phase 3 · active not recruiting Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) · condition mapped CURATED_BROADER · 8,597 trials mapped (2,274 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · condition mapped CURATED_BROADER · 8,597 trials mapped (2,274 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903885NA · active not recruiting A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans · condition mapped CURATED_BROADER · 8,597 trials mapped (2,274 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06149481Phase 1/Phase 2 · recruiting Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) · condition mapped CURATED_BROADER · 8,597 trials mapped (2,274 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820463Phase 2 · recruiting A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer · condition mapped CURATED_BROADER · 8,597 trials mapped (2,274 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958432Phase 2/Phase 3 · recruiting Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) · condition mapped CURATED_EXACT · 8,597 trials mapped (2,274 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |